3GI2
Human dihydrofolate reductase Q35K mutant inhibitor complex
Summary for 3GI2
| Entry DOI | 10.2210/pdb3gi2/pdb |
| Descriptor | Dihydrofolate reductase, N-({4-[(2-amino-6-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl}carbonyl)-L-glutamic acid, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... (4 entities in total) |
| Functional Keywords | dihydrofolate reductase, folate enzyme, active site mutants, nadp, one-carbon metabolism, oxidoreductase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 22689.69 |
| Authors | Cody, V. (deposition date: 2009-03-05, release date: 2009-09-29, Last modification date: 2023-09-06) |
| Primary citation | Gangjee, A.,Li, W.,Kisliuk, R.L.,Cody, V.,Pace, J.,Piraino, J.,Makin, J. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. J.Med.Chem., 52:4892-4902, 2009 Cited by PubMed: 19719239DOI: 10.1021/jm900490a PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.53 Å) |
Structure validation
Download full validation report
